INTRODUCTION
============

Post-micturition dribble (PMD) is classified as a post-micturition symptom and is more common in males. It has traditionally been considered to be a part of the aging process, to have a low prevalence, and to be less bothersome than other lower urinary tract symptoms (LUTS) \[[@B1][@B2][@B3][@B4]\]. Furthermore, available diagnostic tools and treatment options for PMD are lacking \[[@B5][@B6][@B7][@B8]\]. For these reasons, PMD seems to be outside of physicians\' and researchers\' interests.

In contrast with what is traditionally believed, however, recent studies suggest that PMD may be one of the most frequent and bothersome LUTS in males \[[@B9][@B10][@B11][@B12][@B13]\]. Also, it has recently been suggested that phosphodiesterase-5 inhibitors (PDE-5Is) may have a role in relieving PMD \[[@B5][@B8]\]. This evidence makes it necessary to review PMD. Accordingly, in this review, we provide a current perspective on PMD in males with respect to epidemiology, pathophysiology, and treatment.

EPIDEMIOLOGY
============

1. Definition
-------------

The term *PMD* is used to describe the involuntary loss of urine immediately after an individual finishes passing urine, usually after leaving the toilet in males or after rising from the toilet in females. It is classified as a post-micturition symptom, according to the standardization of terminology of LUTS by the International Continence Society \[[@B14]\].

PMD is completely distinguishable from terminal dribble. Terminal dribble is classified as a voiding symptom and is the term used when an individual describes a prolonged final part of micturition when the flow has slowed to a trickle or dribble \[[@B14]\].

The International Prostate Symptom Score (IPSS) is the most widely used tool for the evaluation of LUTS. However, PMD cannot be assessed by using the IPSS, because there are no questions concerning PMD on the IPSS. Therefore, most studies have used the Danish Prostatic Symptom Score (DAN-PSS-1) or questionnaires developed by researchers to assess PMD \[[@B15]\]. However, the DAN-PSS-1 questionnaire does not include information on the frequency of PMD or its effect on quality of life, although the severity of symptoms and associated bother can be assessed. Recently, the Hallym Post-Micturition Dribble Questionnaire (HPMDQ) was introduced to assess PMD ([Supplementary material](#S1){ref-type="supplementary-material"}) \[[@B5][@B8]\]. It was designed by Yang et al. \[[@B5]\] to allow for the assessment of various aspects of PMD, including frequency, severity, bother, quality of life, and response to treatment. However, the HPMDQ has not yet been validated, and further studies are needed to prove its clinical utility.

2. Prevalence
-------------

In a population-based study (EPIC study) that involved more than 8,000 males aged ≥18 years in five Western countries, the prevalence rate of PMD was 5.5% \[[@B4]\]. Another population-based study (Boston Area Community Health \[BACH\] study) involving more than 2,300 males aged 30 to 79 years in the United States reported a prevalence rate of 8.7% \[[@B9]\]. In a Chinese population study, which involved more than 1,500 males aged ≥18 years, the prevalence rate was 9.4% \[[@B16]\]. On the other hand, the population-based Tampere Ageing Male Urologic Study (TAMUS), which involved over 7,000 Finnish males aged 30 to 80 years, revealed a PMD prevalence rate of 58.1% \[[@B10]\]. The internet-based epidemiologic study (Epidemiology of LUTS, EpiLUTS), which involved over 14,000 males ≥18 years in three Western countries, reported a prevalence rate of 29.7% \[[@B11]\]. In a practice-based study that involved more than 1,500 males aged ≥18 years in Southeast Asia, the prevalence rate was 55.0% \[[@B17]\]. In most studies, a positive trend was observed between PMD prevalence and advancing age \[[@B4][@B9][@B10][@B11][@B16]\].

In previous studies, the difference in reported prevalence rates seems to be due to the different definition of PMD and the use of various tools for assessing PMD. For example, some studies used the DAN-PSS-1, whereas other studies used questionnaires developed by the researchers. However, it is noted that PMD is not a rare symptom compared with other LUTS. Furthermore, PMD may be one of the most common LUTS in males.

3. Frequency and amount
-----------------------

Little information is available concerning the frequency and amount of PMD. In a study that involved 138 males aged 20 to 70 years with PMD and other LUTS, 42.8%, 32.6%, and 24.6% of patients experienced PMD 1 of 3 times, 2 of 3 times, and almost always, respectively \[[@B8]\]. Yang et al. \[[@B5]\] assessed the frequency and amount of PMD in 205 males aged ≥40 years with LUTS. In males without ED, 65.7%, 22.9%, and 11.4% of patients experienced PMD 1 of 3 times, 2 of 3 times, and almost always, respectively. On the other hand, in males with ED, 43.2%, 33.0%, and 23.9% of patients experienced PMD, respectively. The amount of PMD in males without ED was approximately 1.2 mL, whereas it was approximately 2.1 mL in males with ED.

4. Quality of life
------------------

In a population-based study that involved 1,709 males aged 18 to 79 years in Finland, the most prevalent LUTS causing moderate or severe bother was PMD \[[@B12]\]. However, from an individual perspective, urge incontinence was the most bothersome symptom. In the TAMUS, PMD was the most bothersome LUTS in males aged 30 to 40 years, but not in other age groups \[[@B13]\]. The BACH study showed that post-micturition symptoms including PMD were indicative of impaired physical and mental health-related quality of life using the Medical Outcomes Study 12-item Short Form Survey (SF-12) \[[@B9]\]. In the Chinese population study, PMD was one of the most bothersome LUTS \[[@B16]\]. A practice-based study performed in Southeast Asia reported that more than half of males felt at least some degree of bother for PMD, similar to other LUTS \[[@B17]\].

In previous studies, the degrees of bother for PMD varied. These results were likely affected by the various tools used to assess the degree of PMD. Also, the results might be affected by whether the study was performed at the population level or at the individual level. At the population level, the degree of bother strongly depends on the frequency of PMD. Meanwhile, at the individual level, the variation in level of bother might determine the most bothersome LUTS. However, like PMD prevalence, it is obvious that PMD does not elicit less discomfort than do other LUTS. Furthermore, it may be one of the most bothersome of the LUTS in males.

5. Association with other LUTS
------------------------------

In the BACH study, 53.4% of males with post-micturition symptoms had PMD alone, and 21% had both PMD and incomplete emptying \[[@B9]\]. A total of 24.8% of males with post-micturition symptoms had no other LUTS. Males with post-micturition symptoms most often had co-occurring frequency (approximately 60%) and more often had co-occurring storage symptoms than voiding symptoms. Conversely, co-occurring post-micturition symptoms were most often seen in males with intermittency (more than 60%) and were more often reported in males with voiding symptoms than in males with storage symptoms. In a practice-based study performed in Southeast Asia, 1.4% of males with any LUTS had only PMD alone \[[@B17]\]. Males with PMD had co-occurring weak stream (47.1%), nocturia (46.4%), and urgency (35.5%). Kobayashi et al. \[[@B18]\] assessed the association between PMD and prostate volume and urinary flow in 172 Japanese males aged 40 to 79 years. They reported that there was no relationship between the presence of PMD and prostate size or abnormal urinary flow. On the other hand, Lee et al. \[[@B19]\] assessed 309 males aged ≥40 years with LUTS and reported that PMD frequency was associated with prostate size but not urinary flow.

Studies on the association between PMD and other LUTS are lacking. However, PMD seems to commonly overlap with other LUTS, thereby causing further aggravation.

6. Association with erectile dysfunction
----------------------------------------

Few studies have specifically assessed the association between PMD and erectile function, although it is well known that LUTS are closely associated with erectile dysfunction (ED). In a practice-based study that involved 1,271 males aged ≥45 years in 12 countries, PMD was associated with reduced rigidity of erections (odds ratio \[OR\], 1.68), reduced ejaculation (OR, 1.79), and pain on ejaculation (OR, 1.66) \[[@B20]\]. However, in the EpiLUTS, PMD was not associated with sexual activity or ED \[[@B21]\]. Recently, Yang et al. \[[@B5]\] assessed the correlation between PMD and ED in 205 Korean males with LUTS aged ≥40 years. PMD was assessed by using a self-administered questionnaire developed by the authors and by using PMD volume. In that study, ED was well correlated with PMD frequency (*r*=0.388) and volume (*r*=0.138). When compared with IPSS measures one-on-one, the *r* for the correlation of PMD frequency with ED was not lower than the correlation for each of the other IPSS measures, but rather was higher than that for some of the other measures (e.g., incomplete emptying and weak stream).

The mechanism through which PMD might be correlated with ED remains unknown. One hypothesis is a weakened urethro-corporocavernosal reflex \[[@B5]\]. During urination, cavernosa muscle contraction and sinusoidal corpora muscle relaxation are suggested to be mediated through the urethro-corporocavernosal reflex \[[@B22]\]. These changes are likely to cause a mild penile tumescence, which can assist in urinary flow and may allow urine to be easily discharged, leading to the prevention of PMD \[[@B22][@B23][@B24]\]. The changes in the anatomical structure of the corpus cavernosum, including the decreased smooth muscle components and enlarged vascular lumens, limit the basic function of the penis, leading to a weakened urethro-corporocavernosal reflex as well as ED \[[@B25][@B26]\]. A weakened urethro-corporocavernosal reflex could interfere with urinary flow in the urethra during urination, leading to PMD. Pelvic floor muscles are another factor that may explain the correlation between PMD and ED. Pelvic floor muscles are considered to be the most important factor for developing PMD \[[@B27]\]. They also play an active role during sexual activity \[[@B1]\].

The association between PMD and ED is not yet clear. However, considering the close association between storage and voiding LUTS and ED, PMD and ED are likely to be associated.

PATHOPHYSIOLOGY
===============

For whatever reason, PMD occurs due to urine residue in the bulbar or prostatic urethra after urination \[[@B7]\]. However, the pathophysiology by which urine residue remains is not fully understood.

One putative mechanism is a weakness or failure of the pelvic floor muscles, especially the bulbocavernosus and ischiocavernosus muscles \[[@B27]\]. Contraction of the pelvic floor muscles empties the residual urine out of the urethra at the end of urination (called *milk-out*). Therefore, weakness or failure of the pelvic floor muscles results in poor milk-out, leading to urine residue. Wille et al. \[[@B28]\] performed voiding cystourethrogram (VCUG) before and after radical prostatectomy to assess whether PMD is associated with altered post-voiding milk-out. Before surgery, no patients with normal milk-out had PMD, whereas 86% of patients without normal milk-out had PMD. After surgery, 87% of patients with abnormal milk-out reported PMD. They postulated that the bulbocavernosus and ischiocavernosus muscles were involved in the milk-out mechanism at the end of urination. Similarly, Bader et al. \[[@B29]\] also performed VCUG before and after radical prostatectomy to determine post-voiding milk-out. They suggested that PMD was associated with the loss of milk-out.

Another putative mechanism is an incompetent external urethral sphincter \[[@B27]\]. At the end of urination, the external urethral sphincter contracts. The urine that remains in the prostate urethra is then drawn back into the bladder (called *milk-back*). An incompetent external urethral sphincter may result in poor milk-back. Immediately after urination, urine trapped in the prostate urethra could fall into the bulbar urethra, leading to urine residue. A similar mechanism can be applied to bladder neck obstruction. Bladder neck obstruction can interfere with milk-back at the end of urination. When the external urethral sphincter relaxes, urine trapped in the prostate urethra could fall into the bulbar urethra, leading to urine residue.

TREATMENTS
==========

Bulbar urethral massage and pelvic floor exercise are known to relieve PMD. Both methods can be used alone or in combination with each other. Considering that a weakness or failure of pelvic floor muscles might cause PMD, it seems plausible that these two treatment methods have been used to relieve PMD \[[@B27]\]. However, few studies have proven the effectiveness of these methods.

Bulbar urethral massage immediately after urination is a self-help technique and is the simplest way to relieve PMD \[[@B30]\]. The patient is taught to place his fingers behind his scrotum immediately after urination and to gently massage his bulbar urethra in a forwards and upwards direction towards the penis. It may be necessary to repeat this technique several times, until the patient is sure that no urine residue remains \[[@B7][@B31][@B32]\]. Similarly, stretching, squeezing, or shaking the penis can help to empty residual urine out of the urethra \[[@B32]\].

Pelvic floor exercise is specifically targeted to the bulbocavernosus and ischiocavernosus muscles \[[@B7][@B32]\]. It can help to place pressure on the bulbar urethra and force out the urine residue. The effect of pelvic floor exercise depends on the weakness of the pelvic floor muscles. Pelvic floor exercise generally does not show an immediate effect; it may take 3 to 6 months to show an adequate effect \[[@B33]\]. It is also difficult to learn and maintain pelvic floor exercise without proper supervision. Paterson et al. \[[@B34]\] compared the effects of counseling, bulbar urethral massage, and pelvic floor exercise on PMD. A total of 49 males with PMD were randomized and followed the treatment specific to each group for 12 weeks. The authors reported that pelvic floor exercise was more effective in relieving PMD than bulbar urethral massage. On the other hand, counseling did not result in improvement. Also, the authors stated that bulbar urethral massage was effective immediately, whereas pelvic floor exercise needed 5 weeks to achieve a proper therapeutic effect. Dorey et al. \[[@B6]\] compared the efficacy of pelvic floor exercise and lifestyle modification on PMD in 36 males with PMD and ED. In males who received both pelvic floor exercise and lifestyle modification, 66.7% of patients at 3 months and 81.0% at 6 months reported no PMD. In males who received lifestyle modification, only 6.7% reported no PMD at 3 months. Also, they stated that bulbocavernosus muscle dysfunction might explain the association between ED and PMD.

Up-to-date, pharmacologic treatment for PMD has not yet been introduced. Recently, Ko et al. \[[@B8]\] assessed the effects of taking udenafil 75 mg, a PDE-5I, once daily, for 12 weeks, on PMD in 138 males with PMD and other LUTS. This randomized, double-blind, placebo-controlled trial first introduced the possibility of drug-based therapy for relieving PMD. They used the HPMDQ to assess the severity of PMD. They reported that PMD was improved in 61.7% of patients in the udenafil group at 12 weeks and in 26.9% of patients in the placebo group. Also, the reduction in PMD volume in the udenafil group was greater than in the placebo group. They suggested that taking udenafil 75 mg once daily may be an effective treatment for PMD.

The mechanisms by which PDE-5I treats PMD are unknown. One putative mechanism is that PDE-5I may strengthen the urethro-corporocavernosal reflex. On urination, sinusoidal corpora muscle relaxation and cavernosa muscle contraction are suggested to be mediated through the urethro-corporocavernosal reflex \[[@B22]\]. These changes seem to cause a mild degree of penile tumescence and stretch, which can assist in urinary flow and may empty the residual urine out of the urethra \[[@B22][@B23][@B24]\]. Other putative mechanisms are associated with the corpus spongiosum and pelvic floor muscles. PDE-5I acts not only on the corpus cavernosum but also on the corpus spongiosum, to restore sinusoidal elasticity, which may correct dilated bulbar urethrae \[[@B8]\]. The pelvic floor muscles, especially the bulbocavernosus and ischiocavernosus muscles, contract to prevent blood from leaking during erections \[[@B35]\]. Like pelvic floor exercise, chronic treatment with a PDE-5I may help to strengthen the pelvic floor muscles.

CONCLUSIONS
===========

PMD is the involuntary loss of urine immediately after urination. In contrast to what has traditionally been believed, it is not rare and does not elicit less discomfort compared with other LUTS. PMD often seems to overlap with other LUTS and to be associated with sexual function. Although the pathophysiology by which PMD occurs is not fully understood, a weakness or failure of pelvic floor muscles is considered to be the most important factor. Bulbar urethral massage and pelvic floor exercise are known to relieve PMD. Although pharmacologic treatment has not yet been introduced, the possibility of treatment with PDE-5Is has recently been suggested. Because available diagnostic tools and treatment options for PMD are lacking, PMD seems to be outside of physicians\' interests. However, recent evidence suggests that PMD needs more attention. More research is needed to fully understand this disorder.
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